85 research outputs found
Morphology Control of Tin Oxide Nanostructures and Sensing Performances for Acetylene Detection
Morphology Control plays an important role in gas sensing properties of metal oxide semiconductor based gas sensors. In this study, various morphologies of SnO2 nanostructures including nanobulks, nanospheres, nanorods, and nanowires were successfully synthesized via a simple hydrothermal method assisted with different surfactants. X-ray powder diffraction and scanning electron microscopy were employed to characterize the prepared products. Gas sensors were fabricated by screen-printing the as-prepared SnO2 nanostructures onto planar ceramic substrates. Moreover, their gas sensing properties were systematically investigated towards acetylene gas (C2H2), an important fault hydrocarbon dissolved in power transformer oil. Experiments indicate that the SnO2 nanowires based sensor exhibits excellent gas sensing properties, such as lower operating temperature, higher gas response, quicker response-recovery time and good stability than those of SnO2 nanobulks, nanospheres and nanorods. These results imply SnO2 nanowires a promising sensing morphology for C2H2 detection and provide us a feasible way to develop high-performance gas sensor by tailoring the microstructures and morphologies of the materials in further
Facile Hydrothermal Synthesis and Basic Gas-Sensing Properties of Two Three-Dimensional Nanostructures of SnO 2
The hierarchical SnO2 sphere-like architecture, consisting of numerous thin nanosheets, was successfully synthesized via a facile hydrothermal method. The structures and morphologies of this hierarchical architecture were characterized in detail by means of powder X-ray diffraction (XRD), field-emission scanning electron microscopy (FE-SEM), and Brunauer-Emmett-Teller (BET). Further comparative experiments of gas-sensing performances of the as-prepared SnO2 were investigated towards ethanol. It shows this three-dimensional, sheet-spheres, SnO2 as a potential gas-sensing material for a broad range of future sensor applications, like sensitive response to other gases such as hydrogen, carbonic oxide, and methane
Recent Advances of SnO2-Based Sensors for Detecting Fault Characteristic Gases Extracted From Power Transformer Oil
Tin oxide SnO2-based gas sensors have been widely used for detecting typical fault characteristic gases extracted from power transformer oil, namely, H2, CO, CO2, CH4, C2H2, C2H4, and C2H6, due to the remarkable advantages of high sensitivity, fast response, long-term stability, and so on. Herein, we present an overview of the recent significant improvement in fabrication and application of high performance SnO2-based sensors for detecting these fault characteristic gases. Promising materials for the sensitive and selective detection of each kind of fault characteristic gas have been identified. Meanwhile, the corresponding sensing mechanisms of SnO2-based gas sensors of these fault characteristic gases are comprehensively discussed. In the final section of this review, the major challenges and promising developments in this domain are also given
Electrospun ZnO–SnO2 Composite Nanofibers and Enhanced Sensing Properties to SF6 Decomposition Byproduct H2S
Hydrogen sulfide (H2S) is an important decomposition component of sulfur hexafluoride (SF6), which has been extensively used in gas-insulated switchgear (GIS) power equipment as insulating and arc-quenching medium. In this work, electrospun ZnO-SnO2 composite nanofibers as a promising sensing material for SF6 decomposition component H2S were proposed and prepared. The crystal structure and morphology of the electrospun ZnO-SnO2 samples were investigated by X-ray diffraction (XRD), scanning electron microscopy (SEM) and transmission electron microscopy (TEM), respectively. The composition of the sensitive materials was analyzed by energy dispersive X-ray spectrometers (EDS) and X-ray photoelectron spectroscopy (XPS). Side heated sensors were fabricated with the electrospun ZnO-SnO2 nanofibers and the gas sensing behaviors to H2S gas were systematically investigated. The proposed ZnO–SnO2 composite nanofibers sensor showed lower optimal operating temperature, enhanced sensing response, quick response/recovery time and good long-term stability against H2S. The measured optimal operating temperature of the ZnO–SnO2 nanofibers sensor to 50 ppm H2S gas was about 250°C with a response of 66.23, which was 6 times larger than pure SnO2 nanofibers sensor. The detection limit of the fabricated ZnO–SnO2 nanofibers sensor toward H2S gas can be as low as 0.5 ppm. Finally, a plausible sensing mechanism for the proposed ZnO–SnO2 composite nanofibers sensor to H2S was also discussed
Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma
The deletion of chromosome 17p (del(17p)) is considered a crucial prognostic factor at the time of diagnosis in patients with multiple myeloma (MM). However, the impact of del(17p) on survival at different clonal sizes at relapse, as well as the patterns of clonal evolution between diagnosis and relapse and their prognostic value, has not been well described. To address these issues, we analyzed the interphase fluorescence in situ hybridization (iFISH) results of 995 newly diagnosed MM (NDMM) patients and 293 patients with MM at their first relapse. Among these patients, 197 had paired iFISH data at diagnosis and first relapse. Our analysis of paired iFISH revealed that a minor clone of del(17p) at relapse but not at diagnosis was associated with poor prognosis in MM (hazard ratio for median overall survival 1.64 vs. 1.44). Fifty-six and 12 patients developed one or more new cytogenetic abnormalities at relapse, mainly del(17p) and gain/amp(1q), respectively. We classified the patients into six groups based on the change patterns in the clonal size of del(17p) between the two time points. Patients who did not have del(17p) during follow-up showed the best outcomes, whereas those who acquired del(17p) during their disease course, experienced compromised survival (median overall survival: 61.3 vs. 49.4 months; hazard ratio =1.64; 95% confidence interval: 1.06-2.56; P<0.05). In conclusion, our data confirmed the adverse impact of a minor clone of del(17p) at relapse and highlighted the importance of designing optimal therapeutic strategies to eliminate high-risk cytogenetic abnormalities (clinicaltrials gov. identifier: NCT04645199)
The nuclear export protein exportin‐1 in solid malignant tumours: From biology to clinical trials
Abstract Background Exportin‐1 (XPO1), a crucial protein regulating nuclear‐cytoplasmic transport, is frequently overexpressed in various cancers, driving tumor progression and drug resistance. This makes XPO1 an attractive therapeutic target. Over the past few decades, the number of available nuclear export‐selective inhibitors has been increasing. Only KPT‐330 (selinexor) has been successfully used for treating haematological malignancies, and KPT‐8602 (eltanexor) has been used for treating haematologic tumours in clinical trials. However, the use of nuclear export‐selective inhibitors for the inhibition of XPO1 expression has yet to be thoroughly investigated in clinical studies and therapeutic outcomes for solid tumours. Methods We collected numerous literatures to explain the efficacy of XPO1 Inhibitors in preclinical and clinical studies of a wide range of solid tumours. Results In this review, we focus on the nuclear export function of XPO1 and results from clinical trials of its inhibitors in solid malignant tumours. We summarized the mechanism of action and therapeutic potential of XPO1 inhibitors, as well as adverse effects and response biomarkers. Conclusion XPO1 inhibition has emerged as a promising therapeutic strategy in the fight against cancer, offering a novel approach to targeting tumorigenic processes and overcoming drug resistance. SINE compounds have demonstrated efficacy in a wide range of solid tumours, and ongoing research is focused on optimizing their use, identifying response biomarkers, and developing effective combination therapies. Key Points Exportin‐1 (XPO1) plays a critical role in mediating nucleocytoplasmic transport and cell cycle. XPO1 dysfunction promotes tumourigenesis and drug resistance within solid tumours. The therapeutic potential and ongoing researches on XPO1 inhibitors in the treatment of solid tumours. Additional researches are essential to address safety concerns and identify biomarkers for predicting patient response to XPO1 inhibitors
- …